The Vision is to ensure equitable access to optimal care for patients with all thoracic malignancies in the UK and Ireland.
The Mission is to support and educate health care professionals, creating a professional community to exchange ideas, information and innovation and to foster the development of research. The overall aim is to represent the needs of patients and improve their outcomes.
BTOG is kindly hosted by UHL NHS Trust and is based at Glenfield Hospital, Leicester. BTOG does not receive any funding from the NHS but is supported through sponsorship and education grants from industry and registration fees.
The BTOG Position Statement 2016 provides the brief background of BTOG and achievements to date and confirms the Core Principles and Key Activities (Education, Research, Representation) of BTOG. A document detailing the future strategic plan for BTOG is in development and will be available in 2017.
British Thoracic Oncology Group Details
Company Number: 9816385 - The Registrar of Companies for England and Wales
Registered address: Adam Longley Accountants Limited, The Old Barn, 1815 Melton Road, Rearsby, Leicestershire, LE7 4YS
VAT Registration: 228944575
Charity number: 1166012
Entered on Register of Charities 11 March 2016
You can view register of charities at www.charitycommission.gov.uk
BTOG Secretariat: BTOG, Glenfield Hospital,
Groby Road, Leicester LE3 9QP England
Tel: 0116 250 2811 | Email: email@example.com
Please click here to see the BTOG Steering Committee (December 2015).
Please click here for the BTOG Annual Report April 2015 to March 2016.
BTOG Chair - From January 2013
Dr Sanjay Popat is Consultant Thoracic Medical Oncologist at the Royal Marsden Hospital and Honorary Clinical Senior Lecturer in the Molecular Genetics and Genomics Group at the National Heart and Lung Institute, Imperial College London.
Dr Popat has published in the fields of genetics, therapeutic biomarkers and medical oncology. He has been awarded nationally and internationally competitive prizes for his research, in addition to 4 research fellowships. He is an active member of the EORTC Lung Group, ETOP and currently chairs the UK NCRI Advanced Diseases Subgroup of the Lung Cancer CSG.
Dr Popat joined the BTOG Steering Committee in 2010 and since then has led on the provision of specialist study days as well as chairing and speaking at many BTOG annual conferences.